4-selenocyanato-N-((4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)phenyl)sulfonyl)butanamide

ID: ALA5200950

PubChem CID: 168290612

Max Phase: Preclinical

Molecular Formula: C22H19F3N4O3SSe

Molecular Weight: 555.44

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(=O)(=O)NC(=O)CCC[Se]C#N)cc2)cc1

Standard InChI:  InChI=1S/C22H19F3N4O3SSe/c1-15-4-6-16(7-5-15)19-13-20(22(23,24)25)27-29(19)17-8-10-18(11-9-17)33(31,32)28-21(30)3-2-12-34-14-26/h4-11,13H,2-3,12H2,1H3,(H,28,30)

Standard InChI Key:  JLXAJJYWGPXHET-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 36  0  0  0  0  0  0  0  0999 V2000
    2.4024    2.4615    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.9899    1.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1648    1.7470    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7523    1.0325    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.4663    0.6191    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0727    1.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4844    1.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3094    1.7425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7212    1.0307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3090    0.3162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4807    0.3162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5463    1.0307    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1013    1.6350    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8611    1.3029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7802    0.5016    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9588    0.3162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5463   -0.3982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7212   -0.3985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3106   -1.1112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7232   -1.8259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3107   -2.5405    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5442   -1.8275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9606   -1.1158    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5755    1.7154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5755    2.5405    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2901    1.3029    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -5.2901    2.1280    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.7523    0.2059    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4024    1.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2274    1.0325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    0.3179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4650    0.3179    0.0000 Se  0  0  0  0  0  2  0  0  0  0  0  0
    4.8775   -0.3964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2901   -1.1110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  1  0
  4  5  2  0
  6  4  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  6  2  0
  9 12  1  0
 12 13  1  0
 13 14  2  0
 15 14  1  0
 16 15  2  0
 16 12  1  0
 16 17  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 20 21  1  0
 22 20  1  0
 23 22  2  0
 17 23  1  0
 14 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
  4 28  2  0
  2 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5200950

    ---

Associated Targets(Human)

NALM-6 (592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 555.44Molecular Weight (Monoisotopic): 556.0295AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Liu J, Zhang L, Guo L, Zeng Y, Guo Q, Yang C, Shu J, Liu W, Yang L..  (2022)  Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells.,  75  [PMID:36395680] [10.1016/j.bmc.2022.117085]

Source